GSK to expand in Cambridge

GSK, the British pharmaceutical giant formerly known as GlaxoSmithKline, is expanding in Cambridge’s Alewife neighborhood with a 155,000-square-foot lease at 200 CambridgePark Drive. GSK already occupies more than 40,000 square feet in the building, bringing its total footprint to around 200,000 square feet starting next year. “We have enjoyed a long-standing relationship with GSK and are excited to support their increasing footprint in the Cambridge area with this lease,” said Chris Rouches, managing director at King Street Properties, which bought 200 Cambridge Park Drive in 2014. “The Cambridge market is tight on space, but we were able to provide GSK with the appropriate space to expand their lab facilities to continue to advance science and develop innovative products.” The six-story building at 200 Cambridge Park Drive spans 222,000 square feet and is fully leased.